Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 116,729 | 119,709 | 98,841 | 122,948 | 329,633 |
| Marketable Securities | 182,776 | 173,421 | 144,258 | 135,677 | N/A |
| Receivables | 43,382 | 51,218 | 38,302 | 23,476 | 17,282 |
| Inventories | 10,254 | 8,135 | 7,942 | 3,980 | 2,021 |
| TOTAL | $361,097 | $360,154 | $295,635 | $292,288 | $353,743 |
| Non-Current Assets | |||||
| PPE Net | 97,443 | 51,122 | 25,433 | 14,315 | 9,501 |
| Other Non-Current Assets | 120,016 | 119,959 | 132,272 | 140,726 | 99,328 |
| TOTAL | $217,459 | $171,081 | $157,705 | $155,041 | $108,829 |
| Total Assets | $578,556 | $531,235 | $453,340 | $447,329 | $462,572 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 417 | 278 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 18,711 | 6,901 | 10,268 | 4,731 | 2,546 |
| Accrued Expenses | 38,287 | 32,555 | 28,945 | 24,358 | 15,483 |
| Other current liabilities | 1,000 | N/A | N/A | N/A | N/A |
| TOTAL | $68,677 | $49,392 | $47,667 | $36,128 | $24,886 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,640 | 9,745 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 26,717 | 14,345 | 14,198 | 11,623 | 25,187 |
| TOTAL | $39,006 | $26,008 | $14,404 | $12,051 | $25,946 |
| Total Liabilities | $107,683 | $75,400 | $62,071 | $48,179 | $50,832 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,731 | 28,514 | 27,450 | 26,576 | 25,411 |
| Common Shares | 30 | 28 | 27 | 27 | 25 |
| Retained earnings | -224,284 | -200,126 | -218,371 | -160,905 | -93,767 |
| Other shareholders' equity | 267 | 230 | 136 | -381 | 0 |
| TOTAL | $470,873 | $455,835 | $391,269 | $399,150 | $411,740 |
| Total Liabilities And Equity | $578,556 | $531,235 | $453,340 | $447,329 | $462,572 |